The US is increasing its supply of medications used to treat injuries that accompany acute radiation syndrome.  This may be an indicator of a looming danger. The Biden regime announced its plan on Wednesday to spend $290 million on Amgen drug Nplate for “radiological and nuclear emergencies.” “As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS),” according to the news release. “ARS, also known as radiation sickness, occurs when a person’s entire body is exposed to a high dose of penetrating radiation, reaching internal organs in a matter of seconds,” HHS said in the release. “Symptoms of ARS injuries include impaired blood clotting as a result of low platelet counts, which can lead to uncontrolled and life-threatening bleeding… (READ MORE)

Category: Featured Articles